Author： Falanga Anna Vignoli Alfonso Marchetti Marina
Publisher： Informa Healthcare
ISSN： 0735-7907
Source： Cancer Investigation, Vol.27, Iss.1, 2009-01, pp. : 7-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Nanotechnology applications in hematological malignancies (Review)
Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. :
Access to resources
Recommend
Role of mTOR in Hematological Malignancies
Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. :
Mammalian target of rapamycin as a target in hematological malignancies
By Kelly Kevin
Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. :
Role of IL9 and STATs in hematological malignancies (Review)
Oncology Letters, Vol. 7, Iss. 3, 2014-03 ,pp. :